Skip to main content
. Author manuscript; available in PMC: 2014 Jan 4.
Published in final edited form as: Nature. 2013 Jun 2;499(7456):88–91. doi: 10.1038/nature12243

Figure 1. FACS analysis during 2° reprogramming of MEF with CD44/ICAM1 double staining.

Figure 1

Loss of CD44 expression was rapidly followed by ICAM1 upregulation and Nanog-GFP expression. By day 12 the majority of cells displayed an ICAM+/CD44− ESC-like profile. Red; Nanog-GFP− cells, Green; Nanog-GFP+ cells.